Delivery Order SPE2DB20D2104-SPE2DB22FS17J
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $15,275.33, is for the delivery of Biktarvy 50-200-25 MG Tablet, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,340.78, is a delivery order for Biktarvy 50-200-25 mg tablet with an ultimate completion date of March 1, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $80,599.23, is for the delivery of Biktarvy 50-200-25 mg tablets. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,704.06 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $184,789.80 firm fixed-price delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $294,670.29, is for the delivery of Biktarvy 50-200-25 mg tablets. The IDC held by Amerisourcebergen with the DLA is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $93,454.18 firm-fixed-price delivery order is for Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, valued at $5,393.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product, to fulfill the medical supply requirements of the DLA. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $111,081.78, is for the delivery of Biktarvy 50-200-25 mg tablets to support military and veterans' healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $205,374.50, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of Biktarvy 50-200-25 mg tablets for the DLA. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS17JDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,200.61 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has an ultimate completion date of March 24, 2022. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a critical vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 3/23/22 |